Molecular identification of Candida isolates by Real‐time PCR‐high‐resolution melting analysis and investigation of the genetic diversity of Candida species

Esmaeel Eghtedar Nejad,Pooya Ghasemi Nejad Almani,Mohammad Ali Mohammadi,Samira Salari
DOI: https://doi.org/10.1002/jcla.23444
IF: 3.124
2020-07-12
Journal of Clinical Laboratory Analysis
Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p><i>Candida </i> species are considered as the cause of one of the most important opportunistic fungal diseases. Accurate identification of <i>Candida </i> species is important because of antifungal susceptibility patterns are different among these species, so proper identification helps in the selection of antifungal drugs for the prevention and treatment. Phenotypic methods for identification of <i>Candida </i> species, which are widely used in clinical microbiology laboratories, have some limitations. Real‐time PCR followed by the high‐resolution melting analysis (HRMA) is a novel approach for the rapid recognition of pathogenic fungi. Molecular phylogeny is essential for obtaining a better understanding of the evolution of the genus <i>Candida </i> and the identification of the relative degree of the <i>Candida </i> species. The purpose of this study was molecular identification of <i>Candida </i> isolates by Real‐time PCR‐high‐resolution melting analysis and investigation of the genetic diversity of <i>Candida </i> species. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Methods</h3><p>Two hundred and thirty‐two <i>Candida </i> isolates including 111 <i>Candida </i> isolates obtained from 96 HIV/AIDS patients and 121 <i>Candida </i> isolates obtained from 98 non‐HIV persons were identified by real‐time PCR and high‐resolution melting curve analysis. To evaluate genetic diversity and relationships among <i>Candida </i> species, PCR products of nine clinical <i>Candida </i> isolates, as a representative of each kind of species, were randomly selected for DNA sequence analysis. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>In HIV/AIDS patients, six species of <i>Candida </i> spp. were identified as follows: <i>C albicans </i> (n = 64; 57.7%), <i>C glabrata </i> (n = 31; 27.92%), <i>C parapsilosis </i> (n = 9; 8.1%), <i>C tropicalis </i> (n = 4; 3.6%), <i>C krusei </i> (n = 2; 1.8%), and <i>C kefyr </i> (n = 1; 0.90%). In non‐HIV persons, we identified eight species of <i>Candida </i> including <i>C albicans </i> (n = 46; 38.33%) followed by <i>C glabrata </i> and <i>C krusei </i> (each one, n = 18; 15%), <i>C tropicalis </i> (n = 13; 10.83%), <i>C lusitaniae </i> (n = 12; 5.17%), <i>C parapsilosis </i> (n = 10; 4.31%), and <i>C kefyr </i> and <i>C guillermondii </i> (each one, n = 2; 1.66%). Also, the phylogenetic analysis showed the presence of two main clades and six separate subclades. Accordingly, about 88.9% of the isolates were located in clade I and 11.10% of the studied isolates were in clade II. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Conclusions</h3><p>Real‐time PCR followed by high‐resolution melting analysis (HRMA) is known as a reliable, fast, and simple approach for detection and accurate identification of <i>Candida </i> species, especially in clinical samples. </p></section>
medical laboratory technology
What problem does this paper attempt to address?